Clinical Significance and Oncogenic Activity of GRWD1 Overexpression in the Development of Colon Carcinoma.

作者: Xing Liu , Yi-Yi Zhang , Guo-Xian Guan , Yuan-Feng Yang , Jin-Fu Zhuang

DOI: 10.2147/OTT.S290475

关键词:

摘要: Objective GRWD1 (glutamate-rich WD40 repeat containing 1) is a multifunctional protein involved in multiple cellular regulatory pathways, particularly those associated with cell growth control. represented as potential oncogene several cancers, however, the function and mechanism of development colon cancer are still unknown. Materials methods IHC was used to detect expression carcinoma tissues. CCK-8, colony formation, EdU were measure proliferation after knockdown overexpression. The distribution cycle analyzed by flow cytometry. effect on migration invasion wound healing transwell assays. Results Overexpression tissues pathological grading, tumor size, N stage, TNM poor survival. had high sensitivity specificity distinguishing from noncancerous tissues, might be served an independent prognosis patients. Knockdown significantly inhibited induced arrest more drug susceptibility, suppressed invasion. exhibited these oncogenic activities its regulation PCNA Ki67, Cyclin A2 B1, ABCC1 GSTP1, MTA1 MTA2. Conclusion may play activity overexpression malignant characteristics survival outcome carcinoma. target for future therapy.

参考文章(36)
Bipin C. Dash, Wafik S. El-Deiry, Cell cycle checkpoint control mechanisms that can be disrupted in cancer. Methods of Molecular Biology. ,vol. 280, pp. 99- 161 ,(2004) , 10.1385/1-59259-788-2:099
Kenneth D. Tew, Glutathione-Associated Enzymes In Anticancer Drug Resistance. Cancer Research. ,vol. 76, pp. 7- 9 ,(2016) , 10.1158/0008-5472.CAN-15-3143
M. Pagano, R. Pepperkok, F. Verde, W. Ansorge, G. Draetta, Cyclin A is required at two points in the human cell cycle. The EMBO Journal. ,vol. 11, pp. 961- 971 ,(1992) , 10.1002/J.1460-2075.1992.TB05135.X
Ian Tomlinson, Mohammad Ilyas, Marco Novelli, Molecular genetics of colon cancer Cancer and Metastasis Reviews. ,vol. 16, pp. 67- 79 ,(1997) , 10.1023/A:1005744323215
Nozomi Sugimoto, Kazumitsu Maehara, Kazumasa Yoshida, Shuhei Yasukouchi, Satoko Osano, Shinya Watanabe, Masahiro Aizawa, Takashi Yugawa, Tohru Kiyono, Hitoshi Kurumizaka, Yasuyuki Ohkawa, Masatoshi Fujita, Cdt1-binding protein GRWD1 is a novel histone-binding protein that facilitates MCM loading through its influence on chromatin architecture Nucleic Acids Research. ,vol. 43, pp. 5898- 5911 ,(2015) , 10.1093/NAR/GKV509
Kimitoshi Kohno, Ke-Yong Wang, Mayu Takahashi, Tomoko Kurita, Yoichiro Yoshida, Masakazu Hirakawa, Yoshikazu Harada, Akihiro Kuma, Hiroto Izumi, Shinji Matsumoto, Mitochondrial transcription factor a and mitochondrial genome as molecular targets for cisplatin-based cancer chemotherapy International Journal of Molecular Sciences. ,vol. 16, pp. 19836- 19850 ,(2015) , 10.3390/IJMS160819836
Todd Riley, Eduardo Sontag, Patricia Chen, Arnold Levine, Transcriptional control of human p53-regulated genes Nature Reviews Molecular Cell Biology. ,vol. 9, pp. 402- 412 ,(2008) , 10.1038/NRM2395
Arnold J. Levine, Moshe Oren, The first 30 years of p53: growing ever more complex Nature Reviews Cancer. ,vol. 9, pp. 749- 758 ,(2009) , 10.1038/NRC2723
Kim Gratenstein, Arnold D. Heggestad, Jenny Fortun, Lucia Notterpek, Dimitri G. Pestov, Bradley S. Fletcher, The WD-repeat protein GRWD1: Potential roles in myeloid differentiation and ribosome biogenesis Genomics. ,vol. 85, pp. 762- 773 ,(2005) , 10.1016/J.YGENO.2005.02.010
Daniel B. Longley, D. Paul Harkin, Patrick G. Johnston, 5-Fluorouracil: mechanisms of action and clinical strategies Nature Reviews Cancer. ,vol. 3, pp. 330- 338 ,(2003) , 10.1038/NRC1074